A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: an interim report of a prospective trial - PubMed (original) (raw)
Clinical Trial
. 1979 Dec;66(12):838-43.
doi: 10.1002/bjs.1800661203.
- PMID: 389338
- DOI: 10.1002/bjs.1800661203
Clinical Trial
A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: an interim report of a prospective trial
M S Elliot et al. Br J Surg. 1979 Dec.
Abstract
A controlled, prospective study comparing streptokinase and heparin treatment has been completed in 51 patients presenting with acute proximal venous thrombosis of less than 8 days' clinical duration. Patients were studied by means of pre-treatment, post-treatment, 3- and 12-monthly phlebography and pulmonary perfusion scanning and were followed up at 3-monthly intervals. Of the 26 patients randomized to receive streptokinase, therapy was stopped in 3 because of complications. Phlebography 5 days after starting treatment showed 80--100 per cent lysis in 17 of the 23 patients who completed the course of streptokinase. Two patients later developed partial rethrombosis. One patient developed an asymptomatic pulmonary embolus during treatment. During follow-up (mean 19 months) only 1 of the 17 patients with 80--100 per cent lysis developed postphlebitic symptoms, 3 patients died of unrelated causes and 1 patient was lost to follow-up. In patients randomized to heparin therapy no significant lysis was achieved in any of the 25 patients and only 2 of these patients were found to have asymptomatic legs on follow-up. Two patients in this group died and autopsy confirmed massive pulmonary embolus during treatment. These data suggest that streptokinase is superior to heparin in the treatment of acute proximal venous thrombosis of less than 1 week's clinical duration especially if the thrombus is largely non-occlusive. It must be stressed that in order to avoid the bleeding complications of thrombolytic therapy, streptokinase must not be used within 10 days of major surgery, or even longer after vascular, neurosurgical or eye operations.
Similar articles
- Comparison of heparin and streptokinase in the treatment of venous thrombosis.
Porter JM, Seaman AJ, Common HH, Rösch J, Eidemiller LR, Calhoun AD. Porter JM, et al. Am Surg. 1975 Sep;41(9):511-19. Am Surg. 1975. PMID: 1101755 Clinical Trial. - Deep vein thrombosis treated with streptokinase or heparin. Follow-up of a randomized study.
Common HH, Seaman AJ, Rösch J, Porter JM, Dotter CT. Common HH, et al. Angiology. 1976 Nov;27(11):645-54. doi: 10.1177/000331977602701105. Angiology. 1976. PMID: 802925 Clinical Trial. - Deep vein thrombosis treated with streptokinase or heparin. A randomized study.
Seaman AJ, Common HH, Rösch J, Dotter CT, Porter JM, Lindell TD, Lawler WL, Schlueter WJ. Seaman AJ, et al. Angiology. 1976 Oct;27(10):549-56. doi: 10.1177/000331977602701001. Angiology. 1976. PMID: 1053467 Clinical Trial. - [Thrombolytic therapy in deep vein phlebitis of the lower limbs].
Malaterre HR, Deharo JC, Daver L, Djiane P. Malaterre HR, et al. Presse Med. 1994 Jan 29;23(3):127-30. Presse Med. 1994. PMID: 8177845 Review. French. - Thrombolytic therapy of acute deep vein thrombosis of the lower limbs: choices, indications and limits.
Mannucci PM. Mannucci PM. Ric Clin Lab. 1984 Oct-Dec;14(4):593-9. doi: 10.1007/BF02906298. Ric Clin Lab. 1984. PMID: 6395297 Review.
Cited by
- Use of thrombolytic drugs in non-coronary disorders.
Verstraete M. Verstraete M. Drugs. 1989 Nov;38(5):801-21. doi: 10.2165/00003495-198938050-00006. Drugs. 1989. PMID: 2689138 Review. - Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting.
AbuRahma AF, Perkins SE, Wulu JT, Ng HK. AbuRahma AF, et al. Ann Surg. 2001 Jun;233(6):752-60. doi: 10.1097/00000658-200106000-00004. Ann Surg. 2001. PMID: 11371733 Free PMC article. Clinical Trial. - The role of thrombolysis in the clinical management of deep vein thrombosis.
Popuri RK, Vedantham S. Popuri RK, et al. Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):479-84. doi: 10.1161/ATVBAHA.110.213413. Arterioscler Thromb Vasc Biol. 2011. PMID: 21325669 Free PMC article. Review. - Systemic thrombolysis in the upper extremity deep vein thrombosis.
Sadeghi R, Safi M. Sadeghi R, et al. ARYA Atheroscler. 2011 Spring;7(1):40-6. ARYA Atheroscler. 2011. PMID: 22577443 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources